MesoMark Falls Short for Early Mesothelioma Diagnosis
The Mesomark blood test for mesothelioma may miss the mark when it comes to diagnosing mesothelioma in its earliest stages. That is the conclusion of a large new study published in the Journal of Clinical Oncology. The report was a meta-analysis of patients in 16 studies on the value of serum mesothelin as a marker for mesothelioma. The studies included data on 4,491 patients, including 1,026 patients with malignant pleural mesothelioma and various control groups. All were measured for the level of mesothelin in their blood serum using the Mesomark test. Mesothelin is a protein present in the cells of the mesothelial membrane which surrounds the lungs and other internal organs. However, mesothelin is overexpressed in several types of tumors, including mesothelioma….